Figure 4
Figure 4. Role of cPLA2α in platelet spreading on fibrinogen. Washed platelets were allowed to adhere to fibrinogen-coated slides for 30 minutes at 37°C in the presence or absence of 20 μM of ADP, 10 μg/mL of CRP, or 1 mM of PAR4 receptor-activating peptide. (A) Platelets were stained with anti-pTyr antibody (green) and rhodamine-phalloidin (red). Images were captured on a deconvolution microscope equipped with a 100× objective. Each panel is representative of 3 separate experiments. Bar represents 10 μm. (B) Pyrrophenone was used at a concentration of 50 μM. (C) SQ29 548 was used at a concentration of 10 μM. In panels B and C, platelets were stained with anti-β3 antibody and rhodamine-phalloidin. Images were captured on an Olympus T-2000 microscope, and platelet surface areas were quantified by computerized image analysis. Data are mean plus or minus SEM of at least 100 platelets per treatment condition.

Role of cPLA2α in platelet spreading on fibrinogen. Washed platelets were allowed to adhere to fibrinogen-coated slides for 30 minutes at 37°C in the presence or absence of 20 μM of ADP, 10 μg/mL of CRP, or 1 mM of PAR4 receptor-activating peptide. (A) Platelets were stained with anti-pTyr antibody (green) and rhodamine-phalloidin (red). Images were captured on a deconvolution microscope equipped with a 100× objective. Each panel is representative of 3 separate experiments. Bar represents 10 μm. (B) Pyrrophenone was used at a concentration of 50 μM. (C) SQ29 548 was used at a concentration of 10 μM. In panels B and C, platelets were stained with anti-β3 antibody and rhodamine-phalloidin. Images were captured on an Olympus T-2000 microscope, and platelet surface areas were quantified by computerized image analysis. Data are mean plus or minus SEM of at least 100 platelets per treatment condition.

Close Modal

or Create an Account

Close Modal
Close Modal